Andrea Alimonti receives esteemed 2024 CloŽtta Prize

- EN - IT
Professor Andrea Alimonti, Group Leader at the Institute of Oncology Research (IOR, affiliated to USI and member of Bios+), has been chosen as the recipient of the 2024 CloŽtta Prize. This prestigious accolade represents a significant recognition of Professor Alimonti’s exceptional contributions to the field of cancer research.

Max CloŽtta Foundation ( http://www.cloetta-foundat­ion.ch/en/ ) aims at supporting and promoting medical research as well as related disciplines of natural sciences in Switzerland. The Foundation annually awards a Prize to support Swiss and foreign scientists who have made exceptional contributions to specific areas of medical research.

Andrea Alimonti is being honoured for his outstanding achievements in his studies on cellular senescence and tumour immunology that have led to the identification of new therapies for metastatic prostate cancer.

The award ceremony will take place in Lausanne on Friday, 29 November 2024.